Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

AstraZeneca PLC ADR (AZN)

NASDAQ
Currency in USD
Disclaimer
76.37
+0.57(+0.75%)
Closed
After Hours
76.63+0.26(+0.34%)

AZN Comments

"We are going with the initiative by the European Commission, which is negotiating with producers, and the negotiations are very advanced, we will very soon take part in (an agreement) with AstraZeneca (NYSE:AZN)." The EU agreed last week to buy at least 300 million doses of AstraZeneca's potential COVID-19 vaccine in its first such advance purchase deal, with others expected to follow. The Czech government has said it intends to initially vaccinate 3.5 million out of the country's 10.7 million population to cover medical and social services staff, elderly and ill citizens. It expects to purchase 7 million doses of a vaccine assuming two shots will be needed for each person.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.